Understanding the interplay between host immunity and Epstein-Barr virus in NPC patients

被引：42
|
作者：
Shen, Yong [1 ,2 ]
Zhang, Suzhan [1 ,2 ]
Sun, Ren [1 ,2 ,3 ]
Wu, Tingting [1 ,2 ,3 ]
Qian, Jing [2 ,4 ]
机构：
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Inst Canc,China Natl Minist Educ,Key Lab Canc Pre, Hangzhou 310009, Zhejiang, Peoples R China
[2] Zhejiang Univ, Sch Med, Collaborat Innovat Ctr Diag & Treatment Infect Di, ZJU UCLA Joint Ctr Med Educ & Res, Hangzhou 310058, Zhejiang, Peoples R China
[3] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA
[4] Zhejiang Univ, Sch Med, Res Ctr Infect & Immun, Hangzhou 310058, Zhejiang, Peoples R China
来源：
EMERGING MICROBES & INFECTIONS | 2015年 / 4卷
基金：
中国国家自然科学基金;
关键词：
adaptive immunity; EBV; immune evasion; innate immunity; NPC; NASOPHARYNGEAL CARCINOMA-CELLS; REGULATORY T-CELLS; MEMBRANE-PROTEIN; NF-KAPPA-B; ANTIGEN-PROCESSING FUNCTION; BURKITTS-LYMPHOMA CELLS; CLASS-II EXPRESSION; COMPLEX CLASS-I; DENDRITIC CELLS; LATENT MEMBRANE-PROTEIN-1;
D O I：
10.1038/emi.2015.20
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Epstein-Barr virus (EBV) has been used as a paradigm for studying host-virus interactions, not only because of its importance as a human oncogenic virus associated with several malignancies including nasopharyngeal carcinoma (NPC) but also owing to its sophisticated strategies to subvert the host antiviral responses. An understanding of the interplay between EBV and NPC is critical for the development of EBV-targeted immunotherapy. Here, we summarize the current knowledge regarding the host immune responses and EBV immune evasion mechanisms in the context of NPC.
引用
收藏
页数：9
相关论文
共 50 条
  • [1] Epstein-Barr virus in the pathogenesis of NPC
    Raab-Traub, N
    SEMINARS IN CANCER BIOLOGY, 2002, 12 (06) : 431 - 441
  • [2] The interplay between Epstein-Barr virus and B lymphocytes: implications for infection, immunity, and disease
    Hatton, Olivia L.
    Harris-Arnold, Aleishia
    Schaffert, Steven
    Krams, Sheri M.
    Martinez, Olivia M.
    IMMUNOLOGIC RESEARCH, 2014, 58 (2-3) : 268 - 276
  • [3] EPSTEIN-BARR VIRUS AND THE ELDERLY HOST
    SCHMADER, KE
    VANDERHORST, CM
    KLOTMAN, ME
    REVIEWS OF INFECTIOUS DISEASES, 1989, 11 (01): : 64 - 73
  • [4] The interplay of host genetic factors and Epstein-Barr virus in the development of nasopharyngeal carcinoma
    Lung, Maria Li
    Cheung, Arthur Kwok Leung
    Ko, Josephine Mun Yee
    Lung, Hong Lok
    Cheng, Yue
    Dai, Wei
    CHINESE JOURNAL OF CANCER, 2014, 33 (11) : 556 - 568
  • [5] The interplay of host genetic factors and Epstein-Barr virus in the development of nasopharyngeal carcinoma
    Maria Li Lung
    Arthur Kwok Leung Cheung
    Josephine Mun Yee Ko
    Hong Lok Lung
    Yue Cheng
    Wei Dai
    ChineseJournalofCancer, 2014, 33 (11) : 556 - 568
  • [6] Host factors associated with the kinetics of Epstein-Barr virus DNA load in patients with primary Epstein-Barr virus infection
    Nakai, Hidetaka
    Kawamura, Yoshiki
    Sugata, Ken
    Sugiyama, Hiroko
    Enomoto, Yoshihiko
    Asano, Yoshizo
    Ihira, Masaru
    Ohashi, Masahiro
    Kato, Tomochika
    Yoshikawa, Tetsushi
    MICROBIOLOGY AND IMMUNOLOGY, 2012, 56 (02) : 93 - 98
  • [7] THE EPSTEIN-BARR VIRUS AS A MODEL OF VIRUS HOST INTERACTIONS
    RICKINSON, AB
    YAO, QY
    WALLACE, LE
    BRITISH MEDICAL BULLETIN, 1985, 41 (01) : 75 - 79
  • [8] Avoiding immunity and apoptosis: Manipulation of the host environment by herpes simplex virus and Epstein-Barr virus
    Hill, AB
    Masucci, MG
    SEMINARS IN VIROLOGY, 1998, 8 (05): : 361 - 368
  • [9] Interplay between Epstein-Barr virus infection and environmental xenobiotic exposure in cancer
    Francisco Aguayo
    Enrique Boccardo
    Alejandro Corvalán
    Gloria M. Calaf
    Rancés Blanco
    Infectious Agents and Cancer, 16
  • [10] Interplay between Epstein-Barr virus infection and environmental xenobiotic exposure in cancer
    Aguayo, Francisco
    Boccardo, Enrique
    Corvalan, Alejandro
    Calaf, Gloria M.
    Blanco, Rances
    INFECTIOUS AGENTS AND CANCER, 2021, 16 (01)
12345